Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: A systematic review

American Journal of Clinical Nutrition

Volumn 89, Issue 6, 2009, Pages

  Fekete, Katalin ^a   Marosvölgyi, Tamás ^a   Jakobik, Viktória ^a   Decsi, Tamás ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTERASE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

CELL MEMBRANE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DIETARY INTAKE; ERYTHROCYTE; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; HUMAN; LIPID COMPOSITION; META ANALYSIS; PHOSPHOLIPID BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIET SUPPLEMENTATION; FEMALE; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; REVIEW; TECHNIQUE;

BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; METHODS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS;

EID: 66849141264     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27230I     Document Type: Conference Paper

References (92)

1. Kris-Etherton PM, Innis S. American Dietetic Association, Dieticians of Canada. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007;107:1599-1611
2. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006;83(suppl)1526S-35S.
3. Simmer K, Schulzke SM, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008;CD000375. (Pubitemid 351807607)
4. Simmer K, Patole SK, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008;CD000376.
5. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2008;CD003205. (Pubitemid 351807633)
6. Hooper L, Thompson RL, Harrison RA, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev 2004;CD003177.
7. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev 2007;CD004597. (Pubitemid 351820443)
8. Turner D, Zlotkin SH, Shah PS, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007;CD006320. (Pubitemid 351805584)
9. Turner D, Steinhart AH, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007;CD006443. (Pubitemid 351805584)
10. McKarney C, Everard M, N'Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2007;CD002201. (Pubitemid 351805321)
11. Sommerfield T, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev 2007;CD003833.
12. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev 2008;CD005169.
13. Farinotti M, Simi S, Di Pietrantonj C, et al. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2007;CD004192.
14. Lim AK, Manley KJ, Roberts MA, Fraenkel MB. Fish oil for kidney transplant recipients. Cochrane Database Syst Rev 2007;CD005282.
15. Silverman DI, Ware JA, Sacks FM. Pasternak RC. Comparison of the absorption and effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil. Am J Clin Nutr 1991;53:1165-1170
16. Di Stasi D, Bernasconi R, Marchioli R, et al. Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur J Clin Pharmacol 2004;60:183-190 (Pubitemid 38757129)
17. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003;133(suppl): 925S-32S. (Pubitemid 36262800)
18. Lands WE. Long-term fat intake and biomarkers. Am J Clin Nutr 1995; 61(suppl)721S-5S.
19. Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006;17:22-27 (Pubitemid 43100299)
20. Katan MB, van Birgelen A, Deslypere JP, Penders M, van Staveren WA. Biological markers of dietary intake, with emphasis on fatty acids. Ann Nutr Metab 1991;35:249-252
21. Fleith M, Clandinin MT. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 2005;45:205-229 (Pubitemid 41657357)
22. Carlson SE. Lessons learned from randomizing infants to marine oil-supplemented formulas in nutrition trials. J Pediatr 1994;125:S33-8.
23. Innis SM. Plasma and red blood cell fatty acid values as indexes of essential fatty acids in the developing organs of infants fed with milk or formulas. J Pediatr 1992;120:S78-86.
24. Cantwell MM. Assessment of individual fatty acid intake. Proc Nutr Soc 2000;59:187-191 (Pubitemid 30604738)
25. Morris DH. Methodologic challenges in designing clinical studies to measure differences in the bioequivalence of n-3 fatty acids. Mol Cell Biochem 2003;246:83-90.
26. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83(suppl): 1467S-76S. (Pubitemid 44713087)
27. Hooper L, Ashton K, Harvey LJ, Decsi T, Fairweather-Tait SJ. Assessing potential biomarkers of micronutrient status by using a systematic review methodology: methods. Am J Clin Nutr 2009;89(suppl):1953S-9S.
28. Allard JP, Kurian R, Aghdassi E, Muggli R, Royall D. Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids 1997;32:535-541 (Pubitemid 27213324)
29. Bønaa KH, Bjerve KS, Nordøy A. Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans. Arterioscler Thromb 1992;12:675-681
30. Brady LM, Lovegrove SS, Lesauvage SV, et al. Increased n26 poly-unsaturated fatty acids do not attenuate the effects of long-chain n-3 polyunsaturated fatty acids on insulin sensitivity or triacylglycerol reduction in Indian Asians. Am J Clin Nutr 2004;79:983-991
31. Christensen JH, Christensen MS, Dyerberg J, Schmidt EB. Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr 1999;70:331-337 (Pubitemid 29407152)
32. Cleland LG, James MJ, Neumann MA, D'Angelo M, Gibson RA. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr 1992;55:395-399
33. Conquer JA, Holub BJ. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J Lipid Res 1998;39:286-292
34. Conquer JA, Cheryk LA, Chan E, Gentry PA, Holub BJ. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb Res 1999;96:239-250 (Pubitemid 29531572)
35. Damsgaard CT, Lauritzen L, Kjaer TM, et al. Fish oil supplementation modulates immune function in healthy infants. J Nutr 2007;137: 1031-1036 (Pubitemid 46596905)
36. DeLany JP, Vivian VM, Snook JT, Anderson PA. Effects of fish oil on serum lipids in men during a controlled feeding trial. Am J Clin Nutr 1990;52:477-485 (Pubitemid 20260620)
37. Dunstan JA, Mori TA, Barden A, et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythro-cyte fatty acid composition. Eur J Clin Nutr 2004;58:429-437 (Pubitemid 38443702)
38. Dyerberg J, Eskesen DC, Andersen PW, et al. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 2004;58: 1062-1070 (Pubitemid 39077153)
39. Engström K, Wallin R, Saldeen T. Effects of Scandinavian caviar paste enriched with a stable fish oil on plasma phospholipid fatty acids and lipid peroxidation. Eur J Clin Nutr 2003;57:1052-1059 (Pubitemid 37121000)
40. Hagve TA, Lie O, Grønn M. The effect of dietary N-3 fatty acids on osmotic fragility and membrane fluidity of human erythrocytes. Scand J Clin Lab Invest 1993;215(suppl):75-84. (Pubitemid 23204331)
41. Helland IB, Saugstad OD, Saarem K, Van Houwelingen AC, Nylander G, Drevon CA. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006;19:397-406. (Pubitemid 44272913)
42. Higgins S, Carroll YL, McCarthy SN, et al. Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. Br J Nutr 2001;85:23-31. (Pubitemid 32156577)
43. Hodge J, Sanders K, Sinclair AJ. Differential utilization of eicosa-pentaenoic acid and docosahexaenoic acid in human plasma. Lipids 1993;28:525-531 (Pubitemid 23177650)
44. Hoffman DR, Theuer RC, Castañeda YS, et al. Maturation of visual acuity is accelerated in breast-fed term infants fed baby food containing DHA-enriched egg yolk. J Nutr 2004;134:2307-2313
45. Itomura M, Hamazaki K, Sawazaki S, et al. The effect of fish oil on physical aggression in schoolchildren: a randomized, double-blind, placebo-controlled trial. J Nutr Biochem 2005;16:163-171 (Pubitemid 40312169)
46. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997;38:2012-2022 (Pubitemid 27468010)
47. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 2004;79:674-681 (Pubitemid 41103914)
48. Khan F, Elherik K, Bolton-Smith C, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res 2003;59:955-962 (Pubitemid 38366251)
49. Laidlaw M, Holub BJ. Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 2003;77:37-42. (Pubitemid 36015370)
50. Mantzioris E, James MJ, Gibson RA, Cleland LG. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994;59:1304-1309 (Pubitemid 2091671)
51. Miles EA, Banerjee T, Calder PC. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins Leukot Essent Fatty Acids 2004;70:529-538 (Pubitemid 38621896)
52. Mills DE, Murthy M, Galey WR. Dietary fatty acids, membrane transport, and oxidative sensitivity in human erythrocytes. Lipids 1995;30: 657-663
53. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr 2003;90:135-145 (Pubitemid 36903411)
54. Otto SJ, van Houwelingen AC, Hornstra G. The effect of different supplements containing docosahexaenoic acid on plasma and erythrocyte fatty acids of healthy non-pregnant women. Nutr Res 2000;20: 917-927 (Pubitemid 30407934)
55. Otto SJ, van Houwelingen AC, Hornstra G. The effect of supplementation with docosahexaenoic and arachidonic acid derived from single cell oils on plasma and erythrocyte fatty acids of pregnant women in the second trimester. Prostaglandins Leukot Essent Fatty Acids 2000;63: 323-328
56. Palozza P, Sgarlata E, Luberto C, et al. n-3 Fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation. Am J Clin Nutr 1996;64:297-304. (Pubitemid 26287316)
57. Park Y, Harris W. EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids 2002;37:941-946 (Pubitemid 36026488)
58. Rees D, Miles EA, Banerjee T, et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 2006;83:331-342 (Pubitemid 44713195)
59. Sanders TAB, Gleason K, Griffin B, Miller GJ. Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr 2006;95:525-531
60. Sanjurjo P, Ruiz-Sanz JI, Jimeno P, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 2004;32:132-136 (Pubitemid 39220533)
61. Smuts CM, Borod E, Peeples JM, Carlson SE. High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 2003;38:407-414 (Pubitemid 36724298)
62. Sørensen NS, Marckmann P, Høy CE, van Duyvenvoorde W, Princen HM. Effect of fish-oil-enriched margarine on plasma lipids, lowdensity- lipoprotein particle composition, size, and susceptibility to oxidation. Am J Clin Nutr 1998;68:235-241
63. Stark KD, Park EJ, Maines VA, Holub BJ. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, doubleblind trial. Am J Clin Nutr 2000;72:389-394
64. Surai PF, MacPherson A, Speake BK, Sparks NH. Designer egg evaluation in a controlled trial. Eur J Clin Nutr 2000;54:298-305. (Pubitemid 30201448)
65. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 2001;131:1918-1927 (Pubitemid 32661059)
66. Vognild E, Elvevoll EO, Brox J, et al. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. Lipids 1998;33:427-436 (Pubitemid 28217389)
67. Wallace JM, McCabe AJ, Robson PJ, et al. Bioavailability of n-3 polyunsaturated fatty acids (PUFA) in foods enriched with micro-encapsulated fish oil. Ann Nutr Metab 2000;44:157-162
68. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000;30:260-274 (Pubitemid 30153668)
69. von Schacky C. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Curr Opin Clin Nutr Metab Care 2008;11:94-99
70. Goldberg RB, Sabharwal AK. Fish oil in the treatment of dyslipidemia. Curr Opin Endocrinol Diabetes Obes 2008;15:167-174
71. Risérus U. Fatty acids and insulin sensitivity. Curr Opin Clin Nutr Metab Care 2008;11:100-105
72. Leichsenring M, Hardenack M, Laryea MD. Relationship among the fatty acid composition of various lipid fractions in normally nourished German adults. Int J Vitam Nutr Res 1992;62:181-185
73. Leichsenring M, Hardenack M, Laryea MD. The fatty acid composition of subcutaneous fat in German adults. Z Ernahrungswiss 1992;31:130-137
74. Decsi T, Koletzko B. Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood. Eur J Pediatr 1994;153: 520-525 (Pubitemid 24210285)
75. Jakobik V, Burus I, Decsi T. Fatty acid composition of erythrocyte membrane lipids in healthy subjects from birth to young adulthood. Eur J Pediatr 2009;168:141-147
76. Nordøy A, Barstad L, Connor WE, Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and trigly-cerides by humans. Am J Clin Nutr 1991;53:1185-1190
77. Zuijdgeest-van Leeuwen SD, Dagnelie PC, Rietveld T, van den Berg JW, Wilson JH. Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br J Nutr 1999; 82:481-488
78. Harris WS, Sands SA, Windsor SL, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004;110:1645-1649
79. Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007;55:217-223
80. Brown AJ, Pang E, Roberts DC. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 1991;54:668-673 (Pubitemid 21898984)
81. Tremoli E, Maderna P, Marangoni F, et al. Prolonged inhibition of platelet aggregation after n2 fatty acid ethyl ester ingestion by healthy volunteers. Am J Clin Nutr 1995;61:607-613
82. Prisco D, Filippini M, Francalanci I, et al. Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes. Am J Clin Nutr 1996;63:925-932 (Pubitemid 26173243)
83. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006;52:2265-2272 (Pubitemid 44925001)
84. Fokkema MR, Smit EN, Martini IA, Woltil HA, Boersma ER, Muskiet FA. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20: 4omega6 and 22:5omega6/22:6omega3. Prostaglandins Leukot Essent Fatty Acids 2002;67:345-356
85. Harris WS, Assaad B, Poston WC. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. Am J Cardiol 2006;98(suppl): 19i-26i. (Pubitemid 44223361)
86. Hoey L, McNulty H, Strain JJ. Studies of biomarker responses to intervention with riboflavin: a systematic review. Am J Clin Nutr 2009; 89(suppl):1960S-80S.
87. Hoey L, Strain JJ, McNulty H. Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. Am J Clin Nutr 2009;89(suppl):1981S-96S.
88. Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009; 89(suppl):1997S-2008S.
89. Harvey LJ, Ashton K, Hooper L, Casgrain A, Fairweather-Tait SJ. Methods of assessment of copper status in humans: a systematic review. Am J Clin Nutr 2009;89(suppl):2009S-24S.
90. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009;89(suppl):2025S-39S.
91. Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr 2009;89(suppl):2040S-51S.
92. Ristic-Medic D, Piskackova Z, Hooper L, et al. Methods of assessment of iodine status in humans: a systematic review. Am J Clin Nutr 2009; 89(suppl):2070S-84S.